SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001326110-23-000023
Filing Date
2023-03-20
Accepted
2023-03-20 08:31:31
Documents
12
Period of Report
2023-03-20
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ibrx-20230320.htm   iXBRL 8-K 63392
  Complete submission text file 0001326110-23-000023.txt   198122

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ibrx-20230320.xsd EX-101.SCH 1924
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ibrx-20230320_lab.xml EX-101.LAB 24128
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ibrx-20230320_pre.xml EX-101.PRE 12526
6 EXTRACTED XBRL INSTANCE DOCUMENT ibrx-20230320_htm.xml XML 4109
Mailing Address 3530 JOHN HOPKINS COURT SAN DIEGO CA 92121
Business Address 3530 JOHN HOPKINS COURT SAN DIEGO CA 92121 (858) 633-0300
ImmunityBio, Inc. (Filer) CIK: 0001326110 (see all company filings)

IRS No.: 431979754 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37507 | Film No.: 23744998
SIC: 2836 Biological Products, (No Diagnostic Substances)